Radiation Oncology Program

Physicians and Staff

Michael C. Garofalo, M.D.

Michael Garofalo, M.D.

Assistant Professor of Radiation Oncology

Education and Degrees

BS: Catholic University of America, Washington, DC
MD: University of Maryland School of Medicine, Baltimore, MD
Residency: University of Chicago, Department of Radiation and Cellular Oncology, Chicago, IL

Areas of Interest

Administrative Assistant

Yvette Green
Phone: (410) 328-2326
Fax: (410) 328-6911

Dr Garofalo's Recent Publications

  1. Garofalo MC, Nichols EM, Regine WF. Is Adjuvant Therapy for Resected Pancreatic Cancer Needed? If Yes, Should it be Chemotherapy or Chemoradiation? GCR 2006, in press.

  2. Patel S, Garofalo MC, Regine WF. Role of Radiotherapy in Treatment of Pancreatic Cancer. (Chapter 81) In: Beger H, Buchler M, Kozarek R, eds. The Pancreas, 2nd Edition Blackwell Publishing, Ltd, 2006, in press.

  3. Yovino S, Darwin P, Daly B, Garofalo MC, Moesinger R. Predicting unresectability in pancreatic cancer patients: the additive effects of CT and endoscopic ultrasound. J Gastrointest Surg 2006, in press.

  4. Garofalo MC, Regine WF, Tan MT. On statistical reanalysis, the EORTC trial was a positive trial for adjuvant chemoradiation in pancreatic cancer. Ann Surg 2006 Aug;244(2):332-333.

  5. Milano MT, Garofalo MC, Chmura SJ, Farrey K, Rash C, Heimann R, Jani AB. Intensity Modulated Radiation Therapy in the Treatment of Gastric Cancer: Early Clinical Outcome and Dosimetric Comparison with Conventional Techniques. Br J Radiol 2006 Jun;79(942):497-503.

  6. Kao J, Milano MT, Javahari A, Garofalo MC, Chmura SJ, Weichselbaum RR, Kron SJ. ?-H2AX as a Therapeutic Target for Improving the Efficacy of Radiation Therapy. Curr Cancer Drug Targets 2006 May;6(3):197-205.

  7. Milano MT, Vokes EE, Kao J, Jackson W, List MA, Stenson KM, Witt ME, Dekker A, MacCracken E, Garofalo MC, Chmura SJ, Weichselbaum RR and Haraf DJ. Intensity modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: Preliminary experience and future directions. Int J Oncol 2006 May;28(5):1141-51.

  8. Kwok Y, DeYoung C, Garofalo MC, Dhople A, Regine W. Radiation Oncology Emergencies. Hematol Oncol Clin North Am 2006 Apr;20(2):505-22.

  9. Garofalo MC, Flannery T, Regine W. The Case for Adjuvant Chemoradiation in Pancreatic Cancer. Best Clinical Practice & Research: Clinical Gastroenterology 2006 Apr;20(2):403-416.

  10. Garofalo M, Malloy P, Amin P, Jaboin J, Gutt R, Van Echo D, Regine W. Treatment of unresectable chemorefractory liver metastases with selective intrahepatic application of yttrium-90 microspheres (SIR-Spheres): Early U.S. experience. Int J Radiat Oncol Biol Phys 2005 63(2);Suppl 1:S161.

  11. Regine WF, Hanna N, Garofalo MC, Doyle A, Arnold S, Kataria R, Simms J, Mohiuddin. Radiation therapy (RT) as a chemosensitizer of gemcitabine (G) in patients with metastatic/unresectable tumors of the gastrointestinal (GI) tract - a phase I/II study exploring a new treatment paradigm. Int J Radiat Oncol Biol Phys 2005 63(2);Suppl 1:S13-14.

  12. Kwok Y, Garofalo M, Regine W. Postoperative Adjuvant Therapy for Pancreatic Cancer. (Chapter 27) In: Von Hoff DD, Evans DB, Hruban RH, eds. Pancreatic Cancer Jones and Bartlett Publishers, 2005 (ISBN 0-7637-2178-6).

  13. Garofalo MC, Chmura SJ. IMRT in the Treatment of Gastrointestinal Tumors. (Chapter 21) In: Mundt AJ, Roeske J, eds. Intensity Modulated Radiation Therapy: A Clinical Perspective, BC Decker, December, 2004 (ISBN 1-55009-246-4).

  14. Chmura SJ, Farrey K, Wang S, Garofalo MC, Roeske JC. Impact of Prolonged Treatment Times in Head and Neck Cancers. (Chapter 18.9) In: Mundt AJ, Roeske, J, eds. Intensity Modulated Radiation Therapy: A Clinical Perspective, BC Decker, December, 2004 (ISBN 1-55009-246-4).

  15. Garofalo MC, Kwok Y, Regine WR. The evolving role of postoperative adjuvant radiation therapy for pancreatic cancer. Surg Oncol Clin N Am 2004 Oct;13(4):589-604.

  16. Chmura S, Garofalo M, Weichselbaum R. Radiosensitization by Gene Therapy. (Chapter 23) In: Curiel DT, Douglas J, eds. Cancer Gene Therapy, Humana Press, September, 2004 (ISBN 1-58829-213-4).

  17. Milano MT, Chmura SJ, Garofalo MC, Rash C, Roeske JC, Kwon O, Connell PP, Heimann R. Intensity Modulated Radiation Therapy (IMRT) in the Treatment of Pancreatic and Bile Duct Malignancies: Toxicity and Outcome. Int J Radiat Oncol Biol Phys 2004 Jun 1;59(2):445-53.

  18. Chmura SJ, Garofalo M, Salama J, Silverberg W, Oh J, Roeske JC. Does the Dose Protraction Inherent to IMRT Decrease Tumor Cell Killing In Vitro. Int J Radiat Oncol Biol Phys 2004 60(1) Suppl 1:S319-S320.

  19. Kao J, Mantz C, Garofalo M, Milano M, Vijayakumar S, Jani A. Treatment-related Sexual Dysfunction in Male Nonprostate Pelvic Malignancies. Sexuality and Disability 2003 Vol 21(1):3-20.

  20. Garofalo M, Haraf D. Re-irradiation of Recurrent and Second Primary Head-and-Neck Cancers. In: American Society of Clinical Oncology 2002 Educational Book, pp578-584, 2002.

  21. Kao J, Garofalo MC, Milano M, Chmura S, Citron J, Haraf D. Reirradiation of Recurrent and Second Primary Head and Neck Malignancies: A Comprehensive Review. Cancer Treat Rev 2003 Feb;29(1):21-30.

  22. Garofalo MC, Haraf DJ. Reirradiation: A Potentially Curative Approach to Locally or Regionally Recurrent Head and Neck Cancer. Curr Opin Oncol 2002 May;14(3):330-3.

back to top


This page was last updated on: April 16, 2008.

For More Information